The global respiratory diagnostics market is expected to grow at a CAGR of 7.1% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.4% from 2017-2027. The market is estimated at $5.32bn in 2016 and $8.00bn in 2022. In 2016, The instruments and devices submarket held the largest market share at 57.7%, followed by the assays and reagents submarket at 23.8%.
How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 197-page report you will receive 56 tables and 118 figures – all unavailable elsewhere.
The 197-page report provides clear detailed insight into the global respiratory diagnostics market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Respiratory Diagnostics market forecasts from 2017-2027
• This report also breaks down the revenue forecast for the global respiratory diagnostics market by product & service: • Instruments and Devices • Assays and Reagents • Services and Software
The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)
• This report also breaks down the revenue forecast for the global respiratory diagnostics market by test type: • Obstructive Sleep Apnoea (OSA) Diagnostic Tests • Imaging Tests • Traditional Diagnostic Tests • Molecular Diagnostic Tests • Other test type
The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)
• This report also breaks down the revenue forecast for the global respiratory diagnostics market by end-users: • Hospitals/Clinic Laboratories • Reference Laboratories • Physician Offices • Other end-users
The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)
• This report also breaks down the revenue forecast for the global respiratory diagnostics market by disease type: • Tuberculosis • Asthma • Lung Cancer • COPD • Other diseases
The forecast of each submarket is further broken down by region (North America, Europe, Asia-Pacific, RoW)
• This report provides individual revenue forecasts to 2027 for these regional and national markets: • North America: the US and Rest of North America • Europe: the UK, Germany, France, Spain, Italy, Russia and Rest of Europe • Asia-Pacific: China, India, Japan, Rest of Asia-Pacific • Rest of the World: Latin America, Middle East and Africa
The forecast of each region is further broken down by product & service, test type, end-users and disease type
• Our study discusses the drivers and restraints that affect the global respiratory diagnostics market. Our study also discusses Porter’s Five Forces analysis that influence the global respiratory diagnostics market
• Our study discusses the selected leading companies that are the major players in the respiratory diagnostics industry.
Visiongain’s study is intended for anyone requiring commercial analyses for the global respiratory diagnostics market. You find data, trends and predictions.
Buy our report today Global Respiratory Diagnostics Market Report 2017-2027: Instruments & Devices, Assays & Reagents, Services & Software, Obstructive Sleep Apnoea (OSA) Diagnostics Tests, Imaging Diagnostic Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, Other Tests, Tuberculosis, Asthma, Lung Cancer, COPD, Other Diseases, Hospitals, Reference Laboratories, Physician Offices, Other End-Users.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Respiratory Diagnostics Market Overview 1.2 Overview of Findings 1.3 Structure of the Report 1.4 Global Respiratory Diagnostics Market Segmentation 1.5 Why You Should Read This Report 1.6 Key Questions Answered by This Analytical Report 1.7 Who is This Report For? 1.8 Methodology 1.9 Frequently Asked Questions (FAQ) 1.10 Associated Visiongain Reports 1.11 About Visiongain
2. Respiratory Diagnostics Market Definition 2.1 What is Respiratory Diagnostics? 2.2 Respiratory Diagnostics Tests 2.2.1 Pulmonary Function Tests 2.2.2 Pulse Oximetry 2.2.3 Capnography 2.2.4 Arterial Blood Gas (ABG) Analysis 2.2.5 Ventilation Perfusion Studies 2.3 Respiratory Diagnostics Market Structure
3. Global Respiratory Diagnostics by Product and Service 2016-2027 3.1 Instruments and Devices Submarket Forecast & Analysis 2017-2027 3.2 Assays and Reagents Submarket Forecast & Analysis 2017-2027 3.3 Services and Software Submarket Forecast & Analysis 2017-2027
4. Global Respiratory Diagnostics by Test Type 2016-2027 4.1 Obstructive Sleep Apnea (OSA) Diagnostic Tests Submarket Forecast & Analysis 2017-2027 4.2 Imaging Tests Submarket Forecast & Analysis 2017-2027 4.3 Traditional Diagnostic Tests Submarket Forecast & Analysis 2017-2027 4.4 Molecular Diagnostic Tests Submarket Forecast & Analysis 2017-2027 4.5 Other Test Type Submarket Forecast & Analysis 2017-2027
7. Regional Respiratory Diagnostics Market Forecasts 2016-2027 7.1 North American Respiratory Diagnostics Market Forecasts 2017-2027 7.1.1 U.S. Respiratory Diagnostics Market Forecasts 2017-2027 7.1.2 Rest of North America Respiratory Diagnostics Market Forecasts 2017-2027 7.2 North American Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027 7.3 North American Respiratory Diagnostics Market Forecasts by Test Type 2017-2027 7.4 North American Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027 7.5 North American Respiratory Diagnostics Market Forecasts by End-Users 2017-2027 7.6 Europe Respiratory Diagnostics Market Forecasts 2017-2027 7.6.1 France Respiratory Diagnostics Market Forecasts 2017-2027 7.6.2 Germany Respiratory Diagnostics Market Forecasts 2017-2027 7.6.3 U.K. Respiratory Diagnostics Market Forecasts 2017-2027 7.6.4 Spain Respiratory Diagnostics Market Forecasts 2017-2027 7.6.5 Italy Respiratory Diagnostics Market Forecasts 2017-2027 7.6.6 Russia Respiratory Diagnostics Market Forecasts 2017-2027 7.6.7 Rest of Europe Respiratory Diagnostics Market Forecasts 2017-2027 7.7 European Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027 7.8 European Respiratory Diagnostics Market Forecasts by Test Type 2017-2027 7.9 European Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027 7.10 European Respiratory Diagnostics Market Forecasts by End-Users 2017-2027 7.11 Asia-Pacific Respiratory Diagnostics Market Forecasts 2017-2027 7.11.1 China Respiratory Diagnostics Market Forecasts 2017-2027 7.11.2 India Respiratory Diagnostics Market Forecasts 2017-2027 7.11.3 Japan Respiratory Diagnostics Market Forecasts 2017-2027 7.11.4 Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market Forecasts 2017-2027 7.12 Asia-Pacific Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027 7.13 Asia-Pacific Respiratory Diagnostics Market Forecasts by Test Type 2017-2027 7.14 Asia-Pacific Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027 7.15 Asia-Pacific Respiratory Diagnostics Market Forecasts by End-Users 2017-2027 7.16 Rest of the World (RoW) Respiratory Diagnostics Market Forecasts 2017-2027 7.16.1 Latin America Respiratory Diagnostics Market Forecasts 2017-2027 7.16.2 Middle East and Africa Respiratory Diagnostics Market Forecasts 2017-2027 7.17 Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Product and Service 2017-2027 7.18 Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Test Type 2017-2027 7.19 Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by Disease Type 2017-2027 7.20 Rest of the World (RoW) Respiratory Diagnostics Market Forecasts by End-Users 2017-2027
8. Drivers & Restraints of the Respiratory Diagnostics Market 8.1 Drivers and Restraints of the Respiratory Diagnostics Market 2017-2027 8.2 Drivers of the Respiratory Diagnostics Market 8.2.1 Increasing Prevalence of Respiratory Disorders 8.2.2 Exponential Rise in Geriatric Population 8.2.3 Technological Advancements 8.3 Restraints of the Respiratory Diagnostics Market 8.3.1 Regulatory Landscape 8.3.2 Reduction in the Usage of Respiratory Diagnostics Tests to Cut Healthcare Spending
9. Leading Companies in the Respiratory Diagnostics Market 9.1 Koninklijke Philips N.V. 9.1.1 Koninklijke Philips N.V. Business Overview 9.1.2 Koninklijke Philips N.V. Product Portfolio 9.1.3 Koninklijke Philips N.V. Financial Overview 9.1.4 Koninklijke Philips N.V. Corporate Strategy 9.2 Becton, Dickinson and Company 9.2.1 Becton, Dickinson and Company Business Overview 9.2.2 Becton, Dickinson and Company Product Portfolio 9.2.3 Becton, Dickinson and Company Financial Overview 9.2.4 Becton, Dickinson and Company Corporate Strategy 9.3 Abbott 9.3.1 Abbott Business Overview 9.3.2 Abbott Product Portfolio 9.3.3 Abbott Financial Overview 9.3.4 Abbott Corporate Strategy 9.4 ThermoFisher Scientific Inc. 9.4.1 ThermoFisher Scientific Inc. Business Overview 9.4.2 ThermoFisher Scientific Inc. Product Portfolio 9.4.3 ThermoFisher Scientific Inc. Financial Overview 9.4.4 ThermoFisher Scientific Inc. Corporate Strategy 9.5 Biomérieux SA 9.5.1 Biomérieux SA Business Overview 9.5.2 Biomérieux SA Product Portfolio 9.5.3 Biomérieux SA Financial Overview 9.5.4 Biomérieux SA Corporate Strategy 9.6 Alere Inc. 9.6.1 Alere Inc. Business Overview 9.6.2 Alere Inc. Product Portfolio 9.6.3 Alere Inc. Financial Overview 9.6.4 Alere Inc. Corporate Strategy 9.7 Bio-Rad Laboratories, Inc. 9.7.1 Bio-Rad Laboratories, Inc. Business Overview 9.7.2 Bio-Rad Laboratories, Inc. Product Portfolio 9.7.3 Bio-Rad Laboratories, Inc. Financial Overview 9.7.4 Bio-Rad Laboratories Inc. Corporate Strategy 9.8 COSMED 9.8.1 COSMED Business Overview 9.8.2 COSMED Product Portfolio 9.8.3 COSMED Financial Overview 9.8.4 COSMED Corporate Strategy 9.9 Seegene Inc. 9.9.1 Seegene Inc. Business Overview 9.9.2 Seegene Inc. Product Portfolio 9.9.3 Seegene Inc. Financial Overview 9.9.4 Seegene Inc. Corporate Strategy 9.10 SDI Diagnostics 9.10.1 SDI Diagnostics Business Overview 9.10.2 SDI Diagnostics Product Portfolio 9.10.3 SDI Diagnostics Financial Overview
10. Qualitative Analysis of the Respiratory Diagnostics Market 10.1 Porter’s Five Forces Analysis of the Respiratory Diagnostics Market 10.2 Rivalry Among Competitors [High] 10.3 Threat of New Entrants [Medium] 10.4 Power of Suppliers [Low] 10.5 Power of Buyers [Medium] 10.6 Threat of Substitutes [Medium]
11. Conclusions 11.1 Current Leading Respiratory Diagnostics Segments 11.1.1 Leading Respiratory Diagnostics Companies 11.1.2 Leading Regional Markets 11.1.3 Emerging Respiratory Diagnostics Markets
Glossary Associated Visiongain Reports Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Tables Table 3.1 Respiratory Diagnostics Submarkets by Product and Service: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 3.2 Instruments and Devices Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 3.3 Assays and Reagents markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 3.4 Services and Software Markets by Region: Forecast ($bn, AGR%, CAGR%) 2016-2027 Table 4.1 Respiratory Diagnostics Submarkets by Test Type: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 4.2 Obstructive Sleep Apnea (OSA) Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 4.3 Imaging Tests Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 4.4 Traditional Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 4.5 Molecular Diagnostic Tests Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 4.5 Other Test Type Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 5.1 Respiratory Diagnostics Submarkets by End-Users: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 5.2 Hospitals/Clinical Laboratories Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 5.3 Reference Laboratories Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 5.4 Physician Offices Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 5.5 Other End-Users Markets by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 6.1 Respiratory Diagnostics Submarkets by Disease Types: Forecast ($bn, AGR%, CAGR%) Table 6.2 Tuberculosis Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 6.3 Asthma Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 6.4 Lung Cancer Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 6.5 Chronic Obstructive Pulmonary Disease (COPD) Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 6.6 Other Diseases Market by Region: Forecast ($bn, AGR%, CAGR%), 2016-2027 Table 7.1 Leading National Respiratory Diagnostics Market Forecast 2016-2021 ($bn, AGR% CAGR%) Table 7.2 Leading National Respiratory Diagnostics Market Forecast 2022-2027 ($bn, AGR% CAGR%) Table 7.3 Regional Respiratory Diagnostics Market Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.4 U.S. Respiratory Diagnostics Market Forecasts by Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.5 Rest of North America Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.6 North American Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.7 North American Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.8 North American Respiratory Diagnostics Market by Disease Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.9 North American Respiratory Diagnostics Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.10 France Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.11 Germany Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.12 U.K. Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.13 Spain Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.14 Italy Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.15 Russia Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.16 Rest of Europe Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.17 European Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.18 European Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.19 European Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.20 European Respiratory Diagnostics Market by End-Users: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.21 China Respiratory Diagnostics Market: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.22 India Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.23 Japan Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.24 Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.25 Asia-Pacific Respiratory Diagnostics Market by Product and Service: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.26 Asia-Pacific Respiratory Diagnostics Market by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.27 Asia-Pacific Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.28 Asia-Pacific Respiratory Diagnostics Market Forecasts by End-Users: Forecast ($bn, AGR% CAGR%) 2016-2027 Table 7.29 Latin America Respiratory Diagnostics Market: Forecasts ($bn, AGR% CAGR%), 2016-2027 Table 7.30 Middle East and Africa Respiratory Diagnostics Market: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.31 RoW Respiratory Diagnostics Market Forecasts, By Product and Service ($bn, AGR% CAGR%) 2016-2027 Table 7.32 RoW Respiratory Diagnostics Market Forecasts by Test Type: Forecast ($bn, AGR% CAGR%), 2016-2027 Table 7.33 RoW Respiratory Diagnostics Market Forecasts by Diseases Type: Forecast ($bn, AGR% CAGR%) 2016-2027 Table 7.34 RoW Respiratory Diagnostics Market Forecasts, By End-Users ($bn, AGR% CAGR%) 2016-2027 Table 8.1 Top 5 Global Respiratory Diseases According to International Respiratory Societies, 2013
List of Figures Figure 1.1 Global Respiratory Diagnostics Market Segmentation Overview Figure 2.1 Global Respiratory Diagnostics Market Segmentation Overview, 2017 Figure 3.1 Global Respiratory Diagnostics Market by Product and Service: (% Share), 2016 Figure 3.2 Respiratory Diagnostics Submarkets by Product and Service: Forecast ($bn), 2016-2027 Figure 3.3 Instruments and Devices Submarkets Forecasts: AGR(%), 2017-2027 Figure 3.4 Global Instruments & Devices Market by Region: Forecast ($bn), 2016-2027 Figure 3.5 Instruments and Devices Market Share by Region: (% Share), 2016-2027 Figure 3.6 Assays and Reagents Submarkets Forecasts: AGR(%), 2017-2027 Figure 3.7 Global Assays and Reagents Market by Region: Forecast ($bn) 2016-2027 Figure 3.8 Assays and Reagents Market Share by Region: (% Share), 2016-2027 Figure 3.9 Services and Software Submarkets Forecasts: AGR(%), 2017-2027 Figure 3.10 Global Services & Software Market by Region: Revenue ($bn), 2016-2027 Figure 3.11 Global Services & Software Market Share by Region: (% Share), 2016-2027 Figure 4.1 Global Respiratory Diagnostics Market by Test Type: (% Share), 2016 Figure 4.2 Respiratory Diagnostics Submarkets by Test Type: Forecast ($bn), 2016-2027 Figure 4.3 Obstructive Sleep Apnea (OSA) Diagnostic Tests Market Forecast: AGR(%), 2017-2027 Figure 4.4 Global OSA Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027 Figure 4.5 Global OSA Diagnostic Tests Market Share by Region: (% Share), 2016-2027 Figure 4.6 Imaging Tests Submarkets Forecasts: AGR(%), 2017-2027 Figure 4.7 Global Imaging Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027 Figure 4.8 Global Imaging Diagnostic Tests Market Share by Region: (% Share), 2016-2027 Figure 4.9 Traditional Diagnostic Tests Submarkets Forecasts: AGR(%), 2017-2027 Figure 4.10 Global Traditional Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027 Figure 4.11 Global Traditional Diagnostic Tests Market Share by Region: (% Share), 2016-2027 Figure 4.12 Molecular Diagnostic Tests Submarkets Forecasts: AGR(%), 2017-2027 Figure 4.13 Global Molecular Diagnostic Tests Market by Region: Forecast ($bn), 2016-2027 Figure 4.14 Global Molecular Diagnostic Tests Market Share by Region: (% Share), 2016-2027 Figure 4.15 Other Test Type Submarkets Forecast: AGR(%), 2017-2027 Figure 4.16 Global Other Diagnostic Test Type Market by Region: Revenue ($bn), 2016-2027 Figure 4.17 Global Other Diagnostic Test Type Market Share by Region: (% Share), 2016-2027 Figure 5.1 Global Respiratory Diagnostics Market by End-Users: (% Share), 2016 Figure 5.2 Respiratory Diagnostics Submarkets by End-Users: Forecast ($bn), 2016-2027 Figure 5.3 Hospital/Clinical Laboratories Market Forecasts: AGR(%), 2017-2027 Figure 5.4 Global Hospitals/Clinical Laboratories Market by Region: Forecast ($bn), 2016-2027 Figure 5.5 Global Hospitals/Clinical Laboratories Market Share by Region: (% Share), 2016-2027 Figure 5.6 Reference Laboratories Submarkets Forecasts: AGR(%), 2017-2027 Figure 5.7 Global Reference Laboratories Market by Region: Forecast ($bn), 2016-2027 Figure 5.8 Global Reference Laboratories Market Share by Region: (% Share), 2016-2027 Figure 5.9 Physician Offices Submarkets Forecasts: AGR(%), 2017-2027 Figure 5.10 Global Physician Offices Market by Region: Forecast ($bn), 2016-2027 Figure 5.11 Global Physician Offices Market Share by Region: (% Share), 2016-2027 Figure 5.12 Other End-Users Submarkets Forecasts: AGR(%), 2017-2027 Figure 5.13 Global Other End-Users Market by Region: Revenue ($bn), 2016-2027 Figure 5.14 Global Other End-Users Market Share by Region: (% Share), 2016-2027 Figure 6.1 Global Respiratory Diagnostics Market by Disease Types: (% Share), 2016 Figure 6.2 Respiratory Diagnostics Submarkets by Disease Types: Forecast ($bn), 2016-2027 Figure 6.3 Tuberculosis Submarkets Forecasts: AGR(%), 2017-2027 Figure 6.4 Global Tuberculosis Disease Market by Region: Forecast ($bn), 2016- 2027 Figure 6.5 Global Tuberculosis Disease Market Share by Region: (% Share), 2016-2027 Figure 6.6 Asthma Submarkets Forecasts: AGR(%), 2017-2027 Figure 6.7 Global Asthma Disease Market by Region: Forecast ($bn), 2016-2027 Figure 6.8 Global Asthma Disease Market Share by Region: (% Share), 2016-2027 Figure 6.9 Lung Cancer Submarkets Forecasts: AGR(%), 2017-2027 Figure 6.10 Global Lung Cancer Disease Market by Region: Forecast ($bn), 2016-2027 Figure 6.11 Global Lung Cancer Disease Market Share by Region: (% Share), 2016-2027 Figure 6.12 Chronic Obstructive Pulmonary Disease (COPD) Submarkets Forecasts: AGR(%), 2017-2027 Figure 6.13 Global Chronic Obstructive Pulmonary Disease (COPD) Market by Region: Forecast ($bn), 2016-2027 Figure 6.14 Global Chronic Obstructive Pulmonary Disease (COPD) Market Share by Region: (% Share), 2016-2027 Figure 6.15 Other Diseases Submarkets Forecasts: AGR(%), 2017-2027 Figure 6.16 Global Other Diseases Market by Region: Forecast ($bn), 2016-2027 Figure 6.17 Global Other Diseases Market Share by Region: (% Share) , 2016-2027 Figure 7.1 Regional Respiratory Diagnostic Markets Forecasts ($bn), 2017-2027 Figure 7.2 North American Respiratory Diagnostics Market Share Analysis by Country ($bn, AGR%), 2016 Figure 7.3 U.S. Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027 Figure 7.4 Rest of North America Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027 Figure 7.5 North American Respiratory Diagnostics Market by Test Type: Forecast ($bn), 2016-2027 Figure 7.6 North American Respiratory Diagnostics Market by Disease Type: Forecast ($bn), 2016-2027 Figure 7.7 North American Respiratory Diagnostics Market by End-Users: Forecast ($bn), 2016-2027 Figure 7.8 European Respiratory Diagnostics Market Share by Country: (%Share), 2016 Figure 7.9 France Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.10 Germany Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.11 U.K. Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.12 Spain Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.13 Italy Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.14 Russia Respiratory Diagnostics Market : Forecasts ($bn), 2016-2027 Figure 7.15 Rest of Europe Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.16 European Respiratory Diagnostics Market by Product and Service: Forecast ($bn), 2016-2027 Figure 7.17 European Respiratory Diagnostics Market by Test Type: Forecast ($bn), 2016-2027 Figure 7.18 European Respiratory Diagnostics Market by Disease Type: Forecast ($bn), 2016-2027 Figure 7.19 European Respiratory Diagnostics Market by End-Users: Forecast ($bn), 2016-2027 Figure 7.20 Asia-Pacific Respiratory Diagnostics Market by Country: Forecast ($bn), 2016 Figure 7.21 China Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.22 India Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.23 Japan Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.24 Rest of Asia-Pacific (APAC) Respiratory Diagnostics Market: Forecasts ($bn), 2016-2027 Figure 7.25 Asia-Pacific Respiratory Diagnostics Market by Product and Service: Forecast ($bn), 2016-2027 Figure 7.26 Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by Test Type: Forecast ($bn), 2016-2027 Figure 7.27 Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by Disease Type: Forecast ($bn), 2016-2027 Figure 7.28 Asia-Pacific Respiratory Diagnostics Market Revenue Analysis by End-Users: Forecast ($bn), 2016-2027 Figure 7.29 Rest of the World (RoW) Respiratory Diagnostics Market Share Analysis by Country: (% Share), 2016-2027 Figure 7.30 Latin America Respiratory Diagnostics Market: Forecast ($bn), 2016-2027 Figure 7.31 Middle East and Africa Respiratory Diagnostics Market: Forecast ($bn), 2016-2027 Figure 7.32 RoW Respiratory Diagnostics Market Revenue Analysis by Product and Service: Forecast ($bn), 2016-2027 Figure 7.33 RoW Respiratory Diagnostics Market Revenue Analysis by Test Type: Forecast ($bn), 2016-2027 Figure 7.34 RoW Respiratory Diagnostics Market Revenue Analysis by Disease Type: Forecast ($bn), 2016-2027 Figure 7.35 RoW Respiratory Diagnostics Market Revenue Analysis by End-Users: Forecast ($bn), 2016-2027 Figure 8.1 Respiratory Diagnostics Market: Drivers and Restraints, 2017-2027 Figure 8.2 Global Ageing Population, 2000 vs 2050 Figure 9.1 Koninklijke Philips N.V., 2016 Annual Revenue by Business Segments Figure 9.2 Koninklijke Philips N.V., Annual Revenue 2012-2016 ($m) Figure 9.3 Becton, Dickinson and Company 2016 Annual Revenue by Business Segments Figure 9.4 Becton, Dickinson and Company Annual Revenue 2012-2016 ($m) Figure 9.5 Abbott 2016 Annual Revenue by Business Segments Figure 9.6 Abbott Annual Revenue 2012-2016 ($m) Figure 9.7 ThermoFisher Scientific Inc. 2016 Annual Revenue by Business Segments Figure 9.8 ThermoFisher Scientific Inc. Annual Revenue 2012- 2016 ( $m) Figure 9.9 Biomérieux SA 2015 Annual Revenue By Business Segments Figure 9.10 Biomérieux SA Annual Revenue (2012-2016) ($m) Figure 9.11 Alere Inc. 2015 Annual Revenue by Business Segments Figure 9.12 Alere Inc. Annual Revenue 2012-2015 ($m) Figure 9.13 Bio-Rad Laboratories, Inc. 2016 Annual Revenue by Business Segments Figure 9.14 Bio-Rad Laboratories, Inc. Annual Revenue 2012-2016 ($m) Figure 10.1 Porter’s Five Forces Analysis of the Respiratory Diagnostics Market, 2017-2027 Figure 11.1 Global Respiratory Diagnostics Market Analysis: Forecast ($bn), 2016-2027 Figure 11.2 Respiratory Diagnostics Market Analysis by Regions: Forecast ($bn), 2016-2027
4Dx Laboratories Abbott Laboratories Affymetrix Inc. Alere, Inc. Apax Partners AU Health Augusta University Australian Pharmacy Sleep Services (APSS) Becton, Dickinson and Company Biomérieux SA Bio-Rad Laboratories, Inc. CareFusion Corporation Clinical Laboratory Improvement Amendments (CLIA) COSMED Diagnostics Development European Commission European Union Food and Drug Administration (FDA) Global Alliance against Chronic Respiratory Disease Goldman Sachs & Co. LLC Hologic Illumina Inc. Inpeco International Respiratory Societies Inverness Medical Canada, Inc. J.P. Morgan Securities LLC JLL Partners Koninklijke Philips N.V. Life Technologies Corp. Morgan Stanley & Co. LLC National Institute on Aging (NIA) P&M Venge Patheon RainDance Technologies, Inc. ResApp Health Limited Respiratory Technologies, Inc. (RespirTech) Royal DSM Samsung SDI Diagnostics Seegene Inc. Seegene Technologies, Inc. Skadden, Arps, Slate, Meagher & Flom LLP Skolkovo Innovation Center SPD Thermo Fisher Scientific Inc. Uppsala University Vyaire Medical Wachtell, Lipton, Rosen & Katz World Health Organizations (WHO)
Download sample pages
Complete the form below to download your free sample pages for Global Respiratory Diagnostics Market Report 2017-2027
Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the...
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
